11:04 AM EDT, 05/12/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Monday morning, rising 0.24% to 1,407.61 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and accommodations booking site trivago (TRVG), which climbed 10% and 5.1%, respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and internet browser company Opera (OPRA), which rose 4.7% and 3.8%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which dropped 7.7% and 4.7%, respectively. They were followed by telecommunications operator Telefonica ( TEF ) and pharmaceutical company Novo Nordisk ( NVO ) , which were down 3.1% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and cruise line operator Carnival (CUK), which advanced 9.1% and 8.5%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 5.3% and 4.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and utilities company National Grid ( NGG ) , which fell 12% and 4.2%, respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which lost 2.3% and 1.7%, respectively.